The Pharmaceutical Packaging Summit 2026 will bring senior packaging executives and solution providers to Boston for two days of focused discussion on the next generation of pharmaceutical packaging. The invitation-only event will take place on 22 and 23 June 2026 at Encore Boston Harbor, in Boston, Massachusetts.

The summit is positioned as a strategic meeting point for packaging leaders working across drug delivery, manufacturing, compliance, sustainability and supply chain performance. As pharmaceutical products become more complex, packaging is increasingly being treated as a critical part of the therapy system, rather than a final step before distribution.

The agenda reflects the major forces reshaping pharmaceutical packaging: aseptic integrity, circularity, regulatory compliance, digital patient interfaces, cold chain resilience, modular execution and the use of artificial intelligence in manufacturing and commercial planning. These themes show how the sector is moving beyond traditional containment toward integrated systems that support safety, traceability and patient outcomes.

Pharmaceutical packaging must now combine sterility, usability, regulatory confidence, sustainability and supply chain resilience in one controlled system.

One of the summit’s key themes will be the relationship between aseptic performance and sustainable design. Pharmaceutical and medical packaging must protect sensitive products and maintain strict safety standards, but the industry is also under pressure to reduce environmental impact, address Scope 3 emissions and design more responsible end-of-life solutions.

This balance is particularly difficult in healthcare packaging because material substitution cannot compromise product integrity. Sterile barriers, cold chain formats, medical device packs and drug delivery systems require proven performance, validation and regulatory acceptance. For packaging suppliers, this creates demand for innovations that can improve sustainability while maintaining the highest levels of safety and quality.

• Aseptic integrity remains central to pharmaceutical product protection.
• AI and automation are expected to influence factory operations and launch planning.
• Cold chain resilience is becoming more important for sensitive therapies.
• Digital interfaces can connect packaging with patient support and compliance.

The 2026 programme will include perspectives from senior industry figures. Giorgio Carbone, manufacturing project associate director at Merck Serono, will discuss how next-generation packaging can balance sterility, sustainable materials and end-of-life considerations. Rahul Mittal, head of strategy and innovation North America at Dr Reddy’s Laboratories, will focus on how sustainability can become a financial and strategic growth lever. Rafael do Prado Souza, global brand lead for rare blood disorders at Sanofi, will explore how AI and data-driven systems can connect R&D with commercial execution.

The summit format is designed around practical business engagement. In addition to expert-led sessions and case studies, the event includes scheduled one-to-one meetings between delegates and solution providers. These meetings are aligned with active business priorities, allowing participants to discuss real packaging challenges, technical requirements and investment decisions in a focused environment.

This structure is relevant because pharmaceutical packaging innovation often depends on close collaboration between brand owners, technology providers, material suppliers, automation specialists and regulatory teams. A new material, device or digital feature cannot succeed in isolation. It must work across filling, validation, logistics, patient use and compliance documentation.

Digital transformation will also be an important part of the discussion. Agentic AI, autonomous factory operations and data-driven portfolio planning are beginning to influence how pharmaceutical companies think about packaging development. These tools may help reduce silos, accelerate launch readiness and improve the connection between manufacturing decisions and patient needs.

For the packaging industry, the Pharmaceutical Packaging Summit 2026 highlights a clear direction of travel. Healthcare packaging is becoming more intelligent, more sustainable and more deeply embedded in product strategy. The sector must continue to deliver uncompromising safety while adapting to new expectations around efficiency, circularity and digital connectivity.

As pharmaceutical supply chains face rising complexity, events focused on packaging strategy are becoming more important. The Boston summit will offer a concentrated view of how leading companies are preparing for the next phase of pharmaceutical packaging, where performance, compliance, sustainability and innovation must advance together.